|
[posting]61655178[/posting] Ich verstehe deine Worte, aber nicht ihre Bedeutung für die Diskussion in diesem Forum. Folgende Aussagen wurden zusätzlich zur 30prozentigen Übernahme von Endocanna Health Anteilen durch Clint Sharples getätigt. (siehe z.B. https://ceo.ca/@thenewswire/heritage-completes-acquisition-o… In connection with the Agreements the Company has appointed Erin Prohaska, Heritage’s Chief Financial Officer as its representative to Endocanna’s board of directors, and Dr. Chris Spooner, Heritage’s Chief Science Officer as an addition to the advisory board. Diesen Teil der Nachricht finde ich besonders spannend. Warum wohl? Des Weiteren sagt Clint Sharples zum Deal und der darin enthaltenen Absicht (Von Kapseln lese ich in keiner Nachricht etwas) folgendes: “We look forward to introducing the Endocanna DNA kit to Canada, and working with the entire team at Endocanna to bring some of our medical formulations to the marketplace.” says Clint Sharples, CEO of Heritage “The information that the DNA kit provides, gives people the opportunity to more effectively use cannabis for their medicinal requirements.” Aus einer älteren Pressemitteilung zu diesem Deal wird folgendes kommuniziert. (siehe z.B. https://ceo.ca/@thenewswire/heritage-signs-agreement-to-acqu… “We are excited to be combining our plans for our own Extraction and Medical Sciences divisions with the technology and expertise that Endocanna brings.” says Dr. Chris Spooner, Chief Science Officer of Heritage “By utilizing the science-based EndoDNA process, we will be better able to assist patients with selecting and dosing by developing formulations that address the unique pharmacogenomics of individuals. This will provide an individualized, customizable approach that will help patients understand the link between cannabinoids and their health and assist them in product selection and dosing.” Und Clint Sharples sagt darin folgendes: “We are looking forward to progressing with this transaction as Endocanna aligns favourably with us and our goals of being a leading provider of medical cannabis formulations.” states Clint Sharples, CEO of Heritage “The worldwide expansion potential for the EndoDNA technology will open doors for Heritage to replicate its extraction services and product offerings for medical patients in multiple markets.” Für Osman und das bessere Verständnis möchte ich im Kontext der Kapseln auf folgende Pressemitteilung vom 30 Mai. 2019 hinweisen: https://ceo.ca/@thenewswire/heritage-signs-processing-and-su… |
|
| aus der Diskussion: | CBD - CANNABIS - Heritage Cannabis-Holdings |
| Autor (Datum des Eintrages): | FoxMen1989 (09.10.19 12:03:25) |
| Beitrag: | 5,053 von 11,871 (ID:61655397) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |